My thoughts and ideas
My thoughts and ideas
In the previous section we examined differential expression of genes from the E-GEOD-50760 data set. In this section we will use the gage package to determine if there are any coordinated differential expression patterns in the data set we used for differential expression, E-GEOD-50760.
generally applicable gene-set enrichment (gage) is a popular bioconductor package for performing gene-set and pathway analysis. The package works independent of sample sizes, experimental designs, assay platforms, and is applicable to both microarray and rnaseq data sets. In this section we will use gage and gene sets from the “Kyoto Encyclopedia of Genes and Genomes” (KEGG) and “Gene Ontology” (GO) databases to perform pathway analysis. Let’s go ahead and install gage and load the differential expression results from the previous section.
# install gage source("https://bioconductor.org/biocLite.R") biocLite("gage") library(gage) # load the differential expression results fro the previous section load(url("http://genomedata.org/gen-viz-workshop/intro_to_deseq2/tutorial/deseq2Data_v1.RData")) # extract the results from the deseq2 data library(DESeq2) tumor_v_normal_DE <- results(deseq2Data, contrast=c("tissueType", "primary colorectal cancer", "normal-looking surrounding colonic epithelium"))
In order to perform our pathway analysis we need a list of pathways and their respective genes. The most common databases for this type of data are KEGG and GO. The gage package has two functions for querying this information in real time, kegg.gsets() and go.gsets(), both of which take a species as an argument and will return a list of gene sets and some helpful meta information for subsetting these list. For the KEGG database object
kg.hsa$kg.sets stores all gene sets for the queried species;
kg.hsa$dise.idx store the indices for those gene sets which are classified as signaling and metabolism and disease respectively. We use this information to extract a list of gene sets for the signaling and metabolism and disease subsets. A similar process is used for the GO gene sets splitting the master gene set into the three gene ontologies: “Biological Process”, “Molecular Function”, and “Cellular Component”.
# set up kegg database kg.hsa <- kegg.gsets(species="hsa") kegg.sigmet.gs <- kg.hsa$kg.sets[kg.hsa$sigmet.idx] kegg.dise.gs <- kg.hsa$kg.sets[kg.hsa$dise.idx] # set up go database go.hs <- go.gsets(species="human") go.bp.gs <- go.hs$go.sets[go.hs$go.subs$BP] go.mf.gs <- go.hs$go.sets[go.hs$go.subs$MF] go.cc.gs <- go.hs$go.sets[go.hs$go.subs$CC]
We have our gene sets now however if you look at one of these objects containing the gene sets you’ll notice that each gene set contains a series of integers. These integers are actually entrez gene identifiers which presents a problem as our DESeq2 results use ensemble ID’s as gene identifiers. We will need to convert our gene identifiers to the same format before we perform the pathway analysis. Fortunately bioconductor maintains genome wide annotation data for many species, you can view these species with the OrgDb bioc view. This makes converting the gene identifiers relatively straight forward, below we use the mapIds() function to query the OrganismDb object for the gene symbol, entrez id, and gene name based on the ensembl id. Because there might not be a one to one relationship with these identifiers we also use
multiVals="first" to specify that only the first identifier should be returned in such cases.
# load in libraries to annotate data source("https://bioconductor.org/biocLite.R") biocLite(c("AnnotationDbi","org.Hs.eg.db")) library(AnnotationDbi) library(org.Hs.eg.db) # annotate the deseq2 results with additional gene identifiers tumor_v_normal_DE$symbol <- mapIds(org.Hs.eg.db, keys=row.names(tumor_v_normal_DE), column="SYMBOL", keytype="ENSEMBL", multiVals="first") tumor_v_normal_DE$entrez <- mapIds(org.Hs.eg.db, keys=row.names(tumor_v_normal_DE), column="ENTREZID", keytype="ENSEMBL", multiVals="first") tumor_v_normal_DE$name <- mapIds(org.Hs.eg.db, keys=row.names(tumor_v_normal_DE), column="GENENAME", keytype="ENSEMBL", multiVals="first")
Before we perform the actuall pathway analysis we need to format our differential expression results into a format suitable for the gage package. Basically this means obtaining the normalized log2 expression values and assigning entrez gene identifiers to these values.
# grab the log fold changes for everything tumor_v_normal_DE.fc <- tumor_v_normal_DE$log2FoldChange names(tumor_v_normal_DE.fc) <- tumor_v_normal_DE$entrez
We can now use the gage() function to obtain the significantly perturbed pathways from our differential expression experiment. By default the gage package performs this analysis while taking into account up and down regulation. Setting
same.dir=FALSE will capture pathways perturbed without taking into account direction. This is generally not recommended for the GO groups as most genes within these gene sets are regulated in the same direction, however the same is not true for KEGG pathways and using this parameter may produce informative results in such cases.
# Run enrichment analysis on all log fc fc.kegg.sigmet.p <- gage(tumor_v_normal_DE.fc, gsets = kegg.sigmet.gs) fc.kegg.dise.p <- gage(tumor_v_normal_DE.fc, gsets = kegg.dise.gs) fc.go.bp.p <- gage(tumor_v_normal_DE.fc, gsets = go.bp.gs) fc.go.mf.p <- gage(tumor_v_normal_DE.fc, gsets = go.mf.gs) fc.go.cc.p <- gage(tumor_v_normal_DE.fc, gsets = go.cc.gs) # covert the kegg results to data frames fc.kegg.sigmet.p.up <- as.data.frame(fc.kegg.sigmet.p$greater) fc.kegg.dise.p.up <- as.data.frame(fc.kegg.dise.p$greater) fc.kegg.sigmet.p.down <- as.data.frame(fc.kegg.sigmet.p$less) fc.kegg.dise.p.down <- as.data.frame(fc.kegg.dise.p$less) # convert the go results to data frames fc.go.bp.p.up <- as.data.frame(fc.go.bp.p$greater) fc.go.mf.p.up <- as.data.frame(fc.go.mf.p$greater) fc.go.cc.p.up <- as.data.frame(fc.go.cc.p$greater) fc.go.bp.p.down <- as.data.frame(fc.go.bp.p$less) fc.go.mf.p.down <- as.data.frame(fc.go.mf.p$less) fc.go.cc.p.down <- as.data.frame(fc.go.cc.p$less)
Which genes are in > 30% of significant pathways in the upregulated GO biological process results (q <= .05)
Two genes are, RPS27A, UBA52. Here is an Rscript to get the correct answer.